US 11597924
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
granted A61KA61K31/7088A61K38/45
Quick answer
US patent 11597924 (Genome editing systems comprising repair-modulating enzyme molecules and methods of their use) held by Editas Medicine, Inc. expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/7088, A61K38/45, A61K38/465, A61K48/005